Allucent

Allucent is a global, full-service CRO that partners with small and mid-size biopharma to advance therapies through every phase of drug development and clinical trials, from early-stage to post-approval. It specializes in oncology, neuroscience, and infectious diseases, with cross-therapeutic experience in rare diseases and advanced therapies. The company came into being in the spring of 2022 through the merger of several high-performance companies serving the specialized needs of small and mid-size biopharma. Allucent has offices across North America, Europe, and the Middle East, and has experience conducting trials in more than 70 countries.

In the spring of 2022, Allucent came into being with the merger of several high-performance companies serving the specialized needs of small and mid-size biopharma. Derived from the Latin verb alluceo, Allucent means to shine a light upon something or to create an opportunity. With a new name and bold branding, Allucent united the company and its employees under one purpose: putting the spotlight on biotech innovators and helping them deliver treatments to patients with unmet needs.

1. 1Contract Research Organization for Biopharma | Allucentallucent.com
2. 2History - Our Journey & Milestones Over the Yearsallucent.com
3. 3About Us - Learn More About Our Vision, Mission & Teamallucent.com
4. 4News - Stay Updated with Our Latest Announcementsallucent.com